Kirkland, WA – According to filings with the U.S. Securities and Exchange Commission, Palo Alto Health Sciences is raising $9,999,999.00 in new funding. Sources indicate as part of senior management Chairman of the Board, Russell Siegelman played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Palo Alto Health Sciences

Palo Alto Health Sciences, Inc. is a privately held Silicon Valley digital therapeutic company at the forefront of revolutionizing behavioral healthcare with evidence based, at-home, drug-free solutions. Our product, Freespira, is an FDA-cleared treatment for individuals suffering from panic disorder, panic attacks and other symptoms of panic.

To learn more about Palo Alto Health Sciences, visit http://freespira.com/

Contact:
Russell Siegelman, Chairman of the Board
800-735-8995
russell.siegelman@freespira.com
https://www.linkedin.com/in/russell-siegelman/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved